波士顿科学Boston Scientific Corporation (BSX) 2023年年度报告「NYSE」.pdf

1、2023 Annual ReportBoston Scientific Corporation300 Boston Scientific WayMarlborough,MA 01752- 2024 Boston Scientific Corporation or its affiliates.All rights reserved.AR2023Boston Scientific 2023 Annual Report31344_030724_BSC_AR_Cover.indd 131344_030724_BSC_AR_Cover.indd 13/8/24 11:43 AM3/8/24 11:43

2、 AM Dear Stockholders:In 2023,we set our goals high at Boston Scientific,aiming to take our innovation,collaboration and growth to the next level.Thanks to the tremendous talent and dedication of our global teams,I am gratified to say that we not only met our goals but exceeded them,achieving one of

3、 the strongest years in company history.Working together,we reached milestone moments that helped lay the groundwork for future success.We launched nearly 90 products,fueled our pipeline with significant merger and acquisition developments,generated clinical evidence through 63 clinical trials that

4、enrolled more than 23,000 patients,enhanced our supply chain agility and continued expanding our digital and operational capabilities.Most importantly,we improved the lives of more than 37 million patients around the world.The key to our successes is our values-driven team of approximately 48,000 em

5、ployees worldwide.Their winning spirit and unwavering focus on patients are what enable Boston Scientific to innovate and execute at such a high level.And were not nearly finished,because our 2023 results reflect a planful long-term strategy intended to establish us as an extraordinary company for y

6、ears to come.2023 ResultsOur full year net sales were$14.2 billion.This represents growth of 12.3 percent on a reported basis,13.1 percent on an operational1 basis and 12.3 percent on an organic2 basis compared to 2022.Our exceptional worldwide performance demonstrates strong double-digit operationa